-transparent.png){kind=logo}
Apolipoproteins B and E were determined in 40 patients with type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia) and in 48 patients with other types of hyperlipoproteinaemia matched for cholesterol and triacylglycerols. In type III patients, apolipoprotein E was increased and apolipoprotein B was lower than in other types of hyperlipoproteinaemia. The apolipoprotein E to apolipoprotein B ratio almost completely discriminated between type III and other types of hyperlipoproteinaemia. Assuming a cut-off value of 0.09 for the apolipoprotein E to apolipoprotein B ratio, diagnostic sensitivity was 95% and specificity was 88%. It is concluded that the apolipoprotein E to apolipoprotein B ratio represents the first-line screening quantity of choice for the identification of patients with type III hyperlipoproteinaemia in the clinical laboratory.
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
June 2000,
The British journal of nutrition,
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
January 1996,
European journal of clinical investigation,
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
June 1984,
European journal of clinical investigation,
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
January 2001,
Annals of clinical biochemistry,
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
January 2012,
Journal of atherosclerosis and thrombosis,
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
August 1977,
Lancet (London, England),
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
May 1994,
Journal of internal medicine,
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
August 2001,
Sexually transmitted infections,
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
January 2015,
Disease markers,
W März, and
G Feussner, and
R Siekmeier, and
B Donnerhak, and
L Schaaf, and
V Ruzicka, and
W Gross
February 2006,
Rinsho byori. The Japanese journal of clinical pathology,
